WHO Technical Working Group Meeting on Revision of the WHO Recommendations for the Production and Control of Inactivated Poliomyelitis Vaccines, Annex 2, TRS No 910

Overview

Inactivated poliomyelitis vaccines (IPV) are products that will play a critical role in the Polio Eradication and Endgame Strategic Plan (2013-2018). It is envisaged that IPV will be used instead of oral poliomyelitis vaccine (OPV) once the world is certified poliomyelitis (polio) free.

In order to ensure that the written standards for IPV will cover the vaccines under development, WHO convened a technical working group on 14-15 May 2013 to discuss the revision of the WHO recommendations on the production and control of IPV which were adopted by the WHO Expert Committee on Biological Standardization in 2000. The attendees included experts from academia, NRAs/NCLs and industry from countries around the world who are involved in the development, manufacture, authorization and testing/release of IPV, including Sabin-based IPV (sIPV), and other new developments of IPV. 

Full version of the WHO Technical Report Series N° 910